Letters to the Editor

Molecular predictors of response and survival following IDH1/2 inhibitor monotherapy in acute myeloid leukemia

Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Henry Ford Health, Michigan, MI
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Rochester, MN
Division of Hematology, Mayo Clinic, Jacksonville, FL
Division of Hematology, Mayo Clinic, Jacksonville, FL
Division of Hematology, Mayo Clinic, Scottsdale, AZ
Division of Hematology, Mayo Clinic, Scottsdale, AZ
Division of Hematology, Mayo Clinic, Scottsdale, AZ
Division of Hematology, Mayo Clinic, Rochester, MN
Haematologica Early view Aug 3, 2023 https://doi.org/10.3324/haematol.2023.283732